Mangoceuticals, Inc. Common Stock

MGRX

Mangoceuticals, Inc. (MGRX) is a biopharmaceutical company focused on the development and commercialization of innovative nutraceutical and pharmaceutical products. The company leverages its expertise in formulation science to create health and wellness products that address various medical and nutritional needs. Mangoceuticals aims to integrate natural ingredients with advanced biomedical research to bring effective solutions to consumers.

$1.07 -0.03 (-2.73%)
🚫 Mangoceuticals, Inc. Common Stock does not pay dividends

Company News

Mangoceuticals Provides Clarification on Launch of Branded GLP-1 Weight-Management Programs
GlobeNewswire Inc. • Mangoceuticals Investor Relations • November 14, 2025

Mangoceuticals launches weight-management programs MangoRx Direct and PeachesRx Direct, enabling patients to access FDA-approved GLP-1 medications like Zepbound and Wegovy through telehealth consultations at $99 per month.

Azz Inc. COO acquires $21.2k in company stock By Investing.com - Investing.com Australia
Investing.com • Brando Bricchi • July 12, 2024

Mangoceuticals, a health and wellness company, has appointed Dr. Douglas Christianson as the new Director of Medical Research and Product Innovation. Dr. Christianson will lead the company's product development efforts, particularly in areas like erectile dysfunction, hair growth, weight loss, and hormone replacement therapies.

Spotting Penny Stocks Before They Explode, Top Tips
PennyStocks • D. Marie • May 22, 2024

Here's some tips for finding penny stocks before they shoot up in value The post Spotting Penny Stocks Before They Explode, Top Tips appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Why Salarius Pharmaceuticals Shares Are Trading Higher By Around 31%; Here Are 20 Stocks Moving Premarket
Benzinga • Avi Kapoor • March 25, 2024

Shares of Salarius Pharmaceuticals, Inc. (NASDAQ: SLRX) rose sharply in today’s pre-market trading following fourth-quarter results. Salarius Pharmaceuticals posted a net loss of $0.9 million, or 22 cents per share for the fourth quarter, narrower than the year-ago loss of $6.4 million, or $2.83 per share, according to data from Benzinga Pro. ...

Sientra, Tesla and GM shares rise and EvGo and Planet Labs slump, along with more stocks on the move
MarketWatch • MarketWatch • June 9, 2023

Shares of Tesla and GM, along with DocuSign and Braze are moving higher on Friday. Planet Labs is headed the other way.

Related Companies